Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Revenue (2017 - 2025)

Historic Revenue for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to $143000.0.

  • Crinetics Pharmaceuticals' Revenue changed N/A to $143000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 4773.82%. This contributed to the annual value of $1.0 million for FY2024, which is 7410.91% down from last year.
  • As of Q3 2025, Crinetics Pharmaceuticals' Revenue stood at $143000.0.
  • In the past 5 years, Crinetics Pharmaceuticals' Revenue registered a high of $3.1 million during Q1 2022, and its lowest value of $143000.0 during Q3 2025.
  • In the last 5 years, Crinetics Pharmaceuticals' Revenue had a median value of $640000.0 in 2024 and averaged $954000.0.
  • As far as peak fluctuations go, Crinetics Pharmaceuticals' Revenue tumbled by 7611.05% in 2024, and later surged by 15839.6% in 2025.
  • Quarter analysis of 5 years shows Crinetics Pharmaceuticals' Revenue stood at $1.1 million in 2021, then tumbled by 34.23% to $709000.0 in 2022, then crashed by 51.2% to $346000.0 in 2023, then rose by 15.32% to $399000.0 in 2024, then crashed by 64.16% to $143000.0 in 2025.
  • Its Revenue stands at $143000.0 for Q3 2025, versus $1.0 million for Q2 2025 and $361000.0 for Q1 2025.